Navigation Links
In Vitro Sciences Sets Growth Plan for Arizona
Date:10/8/2019

In Vitro Sciences (IVS), a prominent network of fertility centers, recently acquired a majority interest in Advanced Fertility Care (AFC), an advanced reproductive services (RE) facility operating in the greater Phoenix area. The two entities are joining forces to expand the availability of RE services to expectant families throughout Arizona and the greater Southwest.

This partnership between IVS and AFC is unique to the specialty in that it will leverage IVS’s affiliation with Women’s Health USA (Whusa), a widely-recognized network of more than 600 ObGyn providers across the nation, including 50 providers in the Phoenix metropolitan area, to drive a new model of comprehensive and high-quality care delivery between obstetrics and fertility services.

Brian Pskowski, President of In Vitro Sciences, commented “In Vitro Sciences has been actively looking for partners who share our mission of creating widespread access to the highest quality care for patients facing fertility issues. Advanced Fertility Care has an excellent reputation in Arizona so it’s only natural to combine efforts to help them achieve their – and our - next level of expansion. We look forward to applying our respective strengths to advancing the care coordination in the reproductive field.”

Dr. Nathaniel Zoneraich, FACOG, the founder and lead physician for AFC, is energized by the new arrangement. “We’ve known for some time about the potential we have to expand our leadership in the Arizona market and beyond. IVS brings us the tools and bench strength to help us realize that goal more quickly. Together we will focus on broadening our strategies to better meet referring ObGyn demand and maximizing quality and convenience of patient care coordination.”

Under this new partnership, the entities will also begin to work on a best approach for geographic expansion throughout the region and on deepening the ancillary services they provide.

Advanced Fertility Care (AFC) serves patients from all over Arizona with the latest fertility treatment options including IUI, IVF, ICSI, embryo biopsy and genetic testing. With primary offices in Scottsdale and Mesa, AFC consistently demonstrates high pregnancy success rates, enabled by the best technology and treatment protocols available. AFC has been recognized as a Center of Excellence by every major insurer.

With a 22-year history in the fertility arena and a comprehensive suite of business management services, In Vitro Sciences (IVS) partners with reproductive endocrinology practices across the United States. IVS got its start in partnership with Women’s Health USA, a national management service organization supporting more than 600 ObGyn providers around the U.S., with more than 50 in Arizona alone. The two entities partner to offer strategic management services for independent practices, including: implementing creative growth strategies supporting streamlined operational costs, payer alignment, merger and acquisition plans, marketing, and risk management services. Its unique partnership model enables physicians and physician groups to maintain their independence while leveraging the resources of a national organization.

Read the full story at https://www.prweb.com/releases/in_vitro_sciences_sets_growth_plan_for_arizona/prweb16625571.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine news :

1. Global In Vitro Fertilization Market 2012-2016 New Research Report at ReportsnReports.com
2. India In Vitro Diagnostics (IVD) Market Analysis and 2018 Forecasts in New Research Report at MarketReportsOnline.com
3. Research on China IVD Reagent (In Vitro Diagnostic Reagent) Industry, 2013-2017
4. MediPoint: In-Vitro Colorectal Cancer Screening Tests - Current and Future Players
5. Global In Vitro Diagnostics Market - Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018
6. BCC Research Publishes a New Report on Global In Vitro Toxicity Testing Market
7. Global In Vitro Diagnostics (IVD) Market 2013
8. Industry Analysis, Size, Share, Growth, Trends and Forecast Research Report Available Online by Researchmoz.us
9. World In Vitro Diagnostics Market Analysed by VPG in In-demand Research Report Available at MarketPublishers.com
10. Chinese Regulations on In-Vitro Diagnostic Reagents Market: Application & Approval 2014 Edition New Study Now Available at MarketReportsOnline.com
11. In Vitro Fertilization at Herzliya Medical Center – an up-and-coming segment of Israel’s Medical Tourism Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/10/2020)... ... 10, 2020 , ... The 2020 Maine Boatbuilders Show has a Guinness World ... printed boat by the Advanced Structures and Composites Center at the University of Maine ... amazing boat! The lead developer will also be giving seminars. We are inviting ...
(Date:1/10/2020)... ... ... WellHaven Pet Health, a family of companion animal veterinary hospitals headquartered in Vancouver, ... LEAD WELL with WOMEN. The community will be showcased at the VMX 2020 Women’s ... WOMEN is to empower women, engage all, connect, and help you lead your best ...
(Date:1/10/2020)... Ill. (PRWEB) , ... January 10, 2020 , ... ... Group (SMG3), has announced that it will be attending the HIMSS (Healthcare Information ... 2020. , HIMSS is the can’t-miss health information and technology event of ...
(Date:1/8/2020)... ... January 08, 2020 , ... ... life sciences teams, announced today that the company is rebranding as Red Nucleus ... learning and performance solutions for the life sciences industry. , The addition ...
(Date:1/8/2020)... CHURCH, Va. (PRWEB) , ... January 09, 2020 ... ... of 30 Pharma Companies, An FDAnews/CenterWatch Webinar, Thursday, Jan. 23, 2020 • 1:30-3:00 ... evidence (RWE) and real world data (RWD) to generate evidence and identify gaps ...
Breaking Medicine News(10 mins):
(Date:1/22/2020)... BRUNSWICK, N.J. (PRWEB) , ... January 22, 2020 , ... ... Patent (US 10,500,240) on Terminalia chebula. This newly granted patent expands Natreon’s strong patent ... trials. , The primary claim in this patent is, “a method of treating ...
(Date:1/12/2020)... ... January 12, 2020 , ... FutuRx, ... Innovation - JJDC, and Takeda Ventures, Inc, operating under a tender from the ... Pharma in collaboration with Ramot at Tel-Aviv University and Glasgow University. , ...
(Date:1/10/2020)... ... January 10, 2020 , ... Mymee, a digital care program aimed at solving ... new website features real client success stories, a simplified description of how ... to self-insured employers and payers. , “There were two key drivers in reimagining ...
Breaking Medicine Technology: